Immuron Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Immuron Stock Summary

Immuron competes with Tscan Therapeutics, In8bio, Phio Pharmaceuticals, Immix Biopharma, and Innate Pharma. Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. Immuron operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.

Immuron Key Financial Ratios

Immuron Key Balance Sheet Accounts

Immuron Key Income Statement Accounts

Immuron Key Cash Accounts

Immuron Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Immuron's current stock value. Our valuation model uses many indicators to compare Immuron value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immuron competition to find correlations between indicators driving Immuron's intrinsic value. More Info.Immuron Ltd ADR is rated third overall in return on equity category among its peers. It also is rated third overall in return on asset category among its peers . At this time, Immuron's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immuron's earnings, one of the primary drivers of an investment's value.

Immuron Ltd ADR Systematic Risk

Today, most investors in Immuron Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Immuron's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Immuron growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Immuron help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immuron Ltd ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immuron Ltd ADR based on widely used predictive technical indicators. In general, we focus on analyzing Immuron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immuron's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.